Project Grant R21AG098632
Award Date 3/1/26
Completion Date 2/29/28
Dollars Obligated $459K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Columbia University's Health Sciences Division a $529,744 Project Grant on February 15, 2026, under the Aging Research program (CFDA 93.866) to investigate the mechanisms driving Alzheimer's disease progression through the entorhinal cortex-hippocampal circuit. The research will utilize in vivo two-photon microscopy and targeted neuronal manipulation techniques to examine three interconnected factors hypothesized...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant totaling $2,957,210 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on September 15, 2025, under the Aging Research program (CFDA 93.866). The grant funds a comprehensive four-year research initiative (completion by August 31, 2029) to decipher the functional role of CD44 astrocytes in Alzheimer's disease (AD) pathology. The research program will deliver...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Trustees of Columbia University in the City of New York $852,273 under the Aging Research program (CFDA 93.866) effective September 1, 2025, through May 31, 2030. This Project Grant supports a comprehensive research initiative investigating the role of RNA modifications in Alzheimer's disease (AD) pathogenesis through an integrated approach combining genetics, multi-omics analysis, and functional validation....
- Federal Grant Award Summary The University of Virginia received a $1.52M Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded May 15, 2025, with a completion date of February 28, 2030. This award supports the development and deployment of magnetic resonance (MR) image-guided focused ultrasound (FUS) technology combined with microbubbles to selectively deliver SHIP-1 neutralizing therapies across the blood-brain barrier to microglial cells in...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $3.23 million through its Aging Research program (CFDA 93.866) to the University of Kansas Center for Research Inc. for a project grant extending from September 30, 2025, through August 31, 2029. The award supports investigative research examining the interplay between neuronal activity, synaptic dysfunction, and mitochondrial abnormalities in Alzheimer's disease. The research will utilize mouse models of...
- Federal Grant Award Summary The National Institute on Aging awarded The Trustees of Columbia University in the City of New York a $3.64M Project Grant under the Aging Research program (CFDA 93.866) effective August 5, 2025, through July 31, 2030. The award funds the FUNGEN-XQTL initiative, which delivers a comprehensive multi-omics research resource and analytical framework for identifying causal genes, cell types, and molecular mechanisms underlying Alzheimer's disease. The project generates...
- Federal Grant Award Summary The National Institute on Aging awarded Columbia University's Health Sciences Division a $6.9 million Project Grant under the Aging Research program (CFDA 93.866) to develop a Multi-Organ AI-Derived Endophenotype (MAE) framework for personalized assessment of Alzheimer's disease and related dementia susceptibility. The grant, effective August 1, 2025 through July 31, 2029, supports the creation of computational diagnostic and prognostic tools by consolidating and...
- Federal Project Grant Summary The National Institute on Aging (NIA) awarded The Washington University a $1.85 million Project Grant under the Aging Research program (CFDA 93.866) effective June 1, 2025, with a project completion date of March 31, 2030. This research initiative, titled "First In Last Out: How Development Informs Neurodegeneration," investigates the relationship between early brain development and late-life Alzheimer's disease (AD) pathology. The project examines whether...
- Federal Grant Award Summary The National Institute on Aging awarded Icahn School of Medicine at Mount Sinai a $2.13 million Project Grant under the Aging Research program (CFDA 93.866) to develop and validate engineered adeno-associated viruses (AAVs) for targeted gene knockdown in Alzheimer's disease-vulnerable neurons. The two-year project, initiated August 1, 2025 and concluding July 31, 2027, focuses on creating AAV constructs containing neuron-specific enhancers and follicle-stimulating...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Trustees of Columbia University in the City of New York $18.3 million under the Aging Research program (CFDA 93.866) for a project period spanning February 1, 2026, through January 31, 2030. This Project Grant supports comprehensive research investigating the association between metal exposures and Alzheimer's disease (AD) and AD-related dementia (ADRD) risk in diverse U.S. populations. The research leverages...